How Singapore Regulates Safety Reporting from Clinical Trials
This article was originally published in SRA
Dorothy Toh SL., Dr Kerwin Low SY., Dr John CW Lim and Ms Julia Leong and Foo Yang Tong give an overview of the regulatory reporting requirements and serious adverse events management system for clinical trials in Singapore.
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.